A Multicenter, Observational, Phase 4 Study (Stellar) to Evaluate the Safety and Tolerability of Lenvatinib (Len) in Patients with Advanced or Unresectable Hepatocellular Carcinoma (Uhcc)
AuthID
P-00W-E6Z
P-00W-E6Z